Wendy DiCicco

Wendy DiCicco

Directeur Financier/CFO chez GENETIX BIOTHERAPEUTICS, INC.

Fortune : 1 585 $ au 31/05/2025

58 ans
Health Technology
Commercial Services
Finance

Profil

Wendy F.
DiCicco
currently serves as Independent Director at EyePoint, Inc. since 2019, Director at National Association of Corporate Directors (Philadelphia), Director at Imvax, Inc. since 2020, Chief Financial Officer at Genetix Biotherapeutics, Inc. starting 2025,.
Member of The American Institute of Certified Public Accountants, Member of National Association of Corporate Directors (Virginia), Member of Pennsylvania Institute of Certified Public Accountants, Member of Women Corporate Directors, Member of The CFO Alliance, and Chief Financial Officer at FerGene, Inc. Former roles include Independent Director at Coherent Corp.
from 2011 to 2017, Director at Golden Dragon Holding Co., Independent Director at SynCardia Systems LLC from 2015 to 2016, Independent Director at SWK Holdings Corp.
from 2022 to 2023, Independent Director at CannaPharmaRx, Inc. from 2015 to 2016, Director at Carmell Regen Med Corp.
from 2018 to 2021, Director at Sincerus Pharmaceuticals, Inc. from 2021 to 2022, Director at ExpressCells, Inc., Chief Financial Officer at DSM Biomedical, Inc. from 1996 to 2008, Chief Financial Officer at Globus Medical, Inc. from 2008 to 2009, Chief Financial Officer at Quench USA, Inc. from 2010 to 2011, Chief Financial & Operating Officer at Centinel Spine LLC from 2017 to 2018, Staff Accountant & Senior Accountant at Deloitte & Touche LLP from 1990 to 1996, Manager-Accounting & Audit at Deloitte LLP (New York) in 1996, Member of Financial Executives International, Chief Financial Officer, Treasurer & VP at Nuron Biotech, Inc. from 2012 to 2014, President & Chief Operating Officer at Camber Spine Technologies LLC from 2014 to 2017, Chief Financial Officer at Renovacor, Inc. from 2019 to 2022, Chief Financial Officer at Akari Therapeutics Plc from 2023 to 2024, and Chief Financial Officer at Renovacor Holdings, Inc. from 2019 to 2022.
Education includes undergraduate studies at Thomas Jefferson University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2025 158 473 915 ( 0,3% ) 1 585 $ 31/05/2025
21/04/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Wendy DiCicco

SociétésPosteDébut
EYEPOINT, INC. Directeur/Membre du Conseil 15/07/2019
GENETIX BIOTHERAPEUTICS, INC. Directeur Financier/CFO 02/06/2025
Directeur Financier/CFO -
Directeur/Membre du Conseil 01/07/2020
Directeur/Membre du Conseil -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░ ░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Anciens postes connus de Wendy DiCicco

SociétésPosteFin
░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Wendy DiCicco

Formation de Wendy DiCicco

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

31

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées31

Electronic Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Distribution Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Finance

Health Technology

Finance

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Wendy DiCicco
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT